Results 191 to 200 of about 32,548 (288)

Preterm meconium‐stained amniotic fluid: A red flag for infection and adverse perinatal outcomes

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 420-427, January 2026.
Abstract Objective Meconium‐stained amniotic fluid (MSAF) is uncommon in preterm deliveries and raises concerns about maternal and neonatal infectious risks. We aimed to evaluate maternal, perinatal, and microbiological outcomes in preterm deliveries complicated by MSAF compared to clear amniotic fluid (AF) and to assess outcomes in preterm versus term
Raneen Abu Shqara, Neta Hoffman, Lior Lowenstein, Maya Frank Wolf   +3 more
wiley   +1 more source

Velamentous Cord Insertion With Vaginal Delivery: A Case Report and Review of the Literature. [PDF]

Cureus
Mpourazanis G, Flindris S, Pantazis K, Alefragkis D, Papalexis P, Korkontzelos I, Kosmas I, Ntanasis A, Serra P, Laganà AS, Schulz-Wendtland R, Tsirkas P.   +11 more
europepmc   +1 more source

Influence of premature rupture of membranes on the peripartum outcomes in vaginally intended breech deliveries at term: A FRABAT study

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 630-638, January 2026.
Abstract Objective This large cohort study investigates the impact of premature rupture of membranes (PROM) on maternal and neonatal outcomes in breech deliveries. The aim is to contribute to a better understanding of vaginal breech delivery and its possible risk factors and to facilitate more informed decision‐making within the counseling process ...
Emmy Rasch, Anna Elisabeth Hentrich, Anne Kristina Kämpf, Eileen Deuster, Samira Catharina Hoock, Frank Louwen, Lukas Jennewein   +6 more
wiley   +1 more source

Impact of Obstetrical Emergency Code (Code Pink) Activation on Maternal and Neonatal Outcomes: A Retrospective Study. [PDF]

Cureus
AlMulai I, Fernandes S, Nizami D, Abuhajjaj TA, Ainawi R, Augustine N, Verghese D, Mallick AK.   +7 more
europepmc   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox, Rosinder Kaur, Kugajeevan Vigneswaran, Rachel Small, Jenny Carter, Keelin O'Donoghue, Alexander E. P. Heazell, Anna L. David, Nigel Simpson, Angharad Care, Lisa Starrs, Andrew Shennan, Catalina María Valencia González, Priya Soma‐Pillay, Leah Fitzsimmons, Adam J. Devall, Arri Coomarasamy, Mid‐trimester Pregnancy Loss Guideline Consensus Panel, Owen Arthurs, Ruth Bender‐Atik, Phil Bennett, Kirstien Boelaert, Elizabeth Bonney, Leanna Brace, Naomi Carlisle, Davide Casagrandi, Manju Chandiramani, Carolyn Chiswick, Alexandra Emms, Stella Fielder, James Goadsby, Laura Goodfellow, Jim Gray, Jemma Johns, Emma Kirk, Will Lester, Sophie Mackay, Maria Memtsa, Katie Morris, Sunbal Mukhtar, Naimah Raza, Rita Sarquis, Neil Sebire, Lucy Smith, Lucy Spencer, Amos Tetteh, Natalie Woodhead   +46 more
wiley   +1 more source

Epidural labor analgesia in a pregnant woman with symptomatic recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease: a case report. [PDF]

JA Clin Rep
Toyama S, Han S.
europepmc   +1 more source

A Rational Approach to Pharmacotherapy in Pregnancy

The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Most pregnant individuals are exposed to at least one medication, whether prescription or over the counter, during pregnancy. Despite the ubiquity of medication use in pregnancy, there remains no standardized framework to guide clinicians in selecting the most appropriate pharmacotherapy that balances maternal needs with fetal safety. This gap
Gregory W. Kirschen, Kevin Watt, Ahizechukwu C. Eke   +2 more
wiley   +1 more source

Zhang's guideline vs. 1994 WHO partograph: comparative effectiveness in managing hypertensive disorder of pregnancy. [PDF]

BMC Pregnancy Childbirth
Sun CJ, Zheng Y, Su S, Liu J, Song W, Jiang H.   +5 more
europepmc   +1 more source

Pregnancies in Women With Long‐Chain Fatty Acid Oxidation Disorders: Results of a European and North American Survey

Journal of Inherited Metabolic Disease, Volume 49, Issue 1, January 2026.
ABSTRACT Long‐chain fatty acid oxidation disorders (lcFAODs) are genetic disorders of energy metabolism that are associated with a risk of metabolic decompensation, especially during catabolic episodes. With improvement in diagnostics and treatment, more women with lcFAODs now reach child‐bearing age.
Sarah C. Grünert, Mirjam Langeveld, Lisa Rudolph, Ute Spiekerkoetter, Allan M. Lund, Annalisa Sechi, Halil Tuna Akar, Karolina M. Stepien, Hanım Aghakishili, Amelie S. Lotz‐Havla, Klaus G. Parhofer, Saadet Mercimek‐Andrews, Havva Yazıcı, Sema Kalkan Uçar, Thomas Scherer, Margreet Wagenmakers, Nur Arslan, Irene Chang, Allie LaTray, Vladimir Bzduch, Ivo Barić, Corina Weigel, Sonja. L. van Ockenburg, Alexander Rennings, Terry G. J. Derks, Alessandro Rossi, David Cassiman, Elaine Murphy   +27 more
wiley   +1 more source

The Role of Lactoferrin in Modulating Inflammation and Preventing Preterm Birth: A Narrative Review. [PDF]

Nutrients
Messina A, El Motarajji S, Masturzo B, Manzoni P.   +3 more
europepmc   +1 more source